Related content

Increased IL17 production correlates with immunosuppression involving myeloid-derived suppressor cells and nutritional impairment in patients with various gastrointestinal cancers

By Yazawa Takashi   Shibata Masahiko   Gonda Kenji   Machida Takeshi   Suzuki Satoshi   Kenjo Akira   Nakamura Izumi   Tsuchiya Takao   Koyama Yoshihisa   Sakurai Kenichi   Shimura Tatsuo   Tomita Ryouichi   Ohto Hitoshi   Gotoh Mitsukazu   Takenoshita Seiichi  

Molecular and Clinical Oncology, Vol. 1, Iss. 4, 2013-07 ,pp. : 675-679

Spandidos Publications

Access to resources Recommend Favorite

Negative Regulation of Myeloid-derived Suppressor Cells in Cancer

By Qu Peng   Boelte Kimberly C.   Lin P. Charles  

Immunological Investigations, Vol. 41, Iss. 6-7, 2012-08 ,pp. : 562-580

Informa Healthcare

Access to resources Recommend Favorite

Metabolism of L-Arginine by Myeloid-Derived Suppressor Cells in Cancer: Mechanisms of T cell suppression and Therapeutic Perspectives

By Raber Patrick   Ochoa Augusto C   Rodríguez Paulo C  

Immunological Investigations, Vol. 41, Iss. 6-7, 2012-08 ,pp. : 614-634

Informa Healthcare

Access to resources Recommend Favorite

Immunosuppression and merkel cell cancer

By Buell J.F.   Trofe J.   Hanaway M.J.   Beebe T.M.   Gross T.G.   Alloway R.R.   First M.R.   Woodle E.S.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1780-1781

Elsevier

Access to resources Recommend Favorite

PGE₂-Driven Induction and Maintenance of Cancer-Associated Myeloid-Derived Suppressor Cells

By Obermajer Nataša   Wong Jeffrey L.   Edwards Robert P.   Odunsi Kunle   Moysich Kirsten   Kalinski Pawel  

Immunological Investigations, Vol. 41, Iss. 6-7, 2012-08 ,pp. : 635-657

Informa Healthcare

Access to resources Recommend Favorite